Clonazepam (Page 9 of 9)

PRINCIPAL DISPLAY PANEL – BLISTER – 0.125 MG

Clonazepam ODT, USP 0.125 mg -- Blister
(click image for full-size original)

Clonazepam ODT, USP 0.125 mg — Blister

Clonazepam ODT, USP 0.125 mg -- Blister
(click image for full-size original)

Clonazepam ODT, USP 0.125 mg — Blister

PRINCIPAL DISPLAY PANEL – BLISTER – 0.25 MG

Clonazepam ODT, USP 0.25 mg -- Blister
(click image for full-size original)

Clonazepam ODT, USP 0.25 mg — Blister

Clonazepam ODT, USP 0.25 mg -- Blister
(click image for full-size original)

Clonazepam ODT, USP 0.25 mg — Blister

PRINCIPAL DISPLAY PANEL – BLISTER – 0.5 MG

Clonazepam ODT, USP 0.5 mg -- Blister
(click image for full-size original)

Clonazepam ODT, USP 0.5 mg — Blister

PRINCIPAL DISPLAY PANEL – BLISTER – 1 MG

Clonazepam ODT, USP 1 mg -- Blister
(click image for full-size original)

Clonazepam ODT, USP 1 mg — Blister

PRINCIPAL DISPLAY PANEL – BLISTER – 2 MG

Clonazepam ODT, USP 2 mg -- Blister
(click image for full-size original)

Clonazepam ODT, USP 2 mg — Blister

Clonazepam ODT, USP 2 mg -- Blister
(click image for full-size original)

Clonazepam ODT, USP 2 mg — Blister

PRINCIPAL DISPLAY PANEL – CARTON – 0.125 MG

This is the 0.125 mg carton
(click image for full-size original)
0.125 mg carton
(click image for full-size original)

0.125 mg carton

PRINCIPAL DISPLAY PANEL – CARTON – 0.25 MG

This is the 0.25 mg carton.
(click image for full-size original)
0.25 mg carton.
(click image for full-size original)

0.25 mg carton.

PRINCIPAL DISPLAY PANEL – CARTON – 0.5 MG

This is the 0.5 mg carton
(click image for full-size original)

PRINCIPAL DISPLAY PANEL – CARTON – 1 MG

This is the 1 mg carton
(click image for full-size original)

PRINCIPAL DISPLAY PANEL – CARTON – 2 MG

This is the 2 mg carton
(click image for full-size original)
2 mg carton
(click image for full-size original)

2 mg carton

CLONAZEPAM
clonazepam tablet, orally disintegrating
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49884-306
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLONAZEPAM (CLONAZEPAM) CLONAZEPAM 0.125 mg
Inactive Ingredients
Ingredient Name Strength
ASPARTAME
CROSPOVIDONE
MAGNESIUM STEARATE
MANNITOL
SILICON DIOXIDE
SORBITOL
SODIUM LAURYL SULFATE
TALC
Product Characteristics
Color white Score no score
Shape ROUND Size 6mm
Flavor Imprint Code K5
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:49884-306-02 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077171 08/05/2005
CLONAZEPAM
clonazepam tablet, orally disintegrating
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49884-307
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLONAZEPAM (CLONAZEPAM) CLONAZEPAM .25 mg
Inactive Ingredients
Ingredient Name Strength
ASPARTAME
CROSPOVIDONE
MAGNESIUM STEARATE
MANNITOL
SILICON DIOXIDE
SORBITOL
SODIUM LAURYL SULFATE
TALC
Product Characteristics
Color white Score no score
Shape ROUND Size 6mm
Flavor Imprint Code K6
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:49884-307-02 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077171 08/05/2005
CLONAZEPAM
clonazepam tablet, orally disintegrating
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49884-308
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLONAZEPAM (CLONAZEPAM) CLONAZEPAM .5 mg
Inactive Ingredients
Ingredient Name Strength
ASPARTAME
CROSPOVIDONE
MAGNESIUM STEARATE
MANNITOL
SILICON DIOXIDE
SORBITOL
SODIUM LAURYL SULFATE
TALC
Product Characteristics
Color white Score no score
Shape ROUND Size 6mm
Flavor Imprint Code K7
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:49884-308-02 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077171 08/05/2005
CLONAZEPAM
clonazepam tablet, orally disintegrating
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49884-309
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLONAZEPAM (CLONAZEPAM) CLONAZEPAM 1 mg
Inactive Ingredients
Ingredient Name Strength
ASPARTAME
CROSPOVIDONE
MAGNESIUM STEARATE
MANNITOL
SILICON DIOXIDE
SORBITOL
SODIUM LAURYL SULFATE
TALC
Product Characteristics
Color white Score no score
Shape ROUND Size 6mm
Flavor Imprint Code K8
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:49884-309-02 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077171 08/05/2005
CLONAZEPAM
clonazepam tablet, orally disintegrating
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49884-310
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLONAZEPAM (CLONAZEPAM) CLONAZEPAM 2 mg
Inactive Ingredients
Ingredient Name Strength
ASPARTAME
CROSPOVIDONE
MAGNESIUM STEARATE
MANNITOL
SILICON DIOXIDE
SORBITOL
SODIUM LAURYL SULFATE
TALC
Product Characteristics
Color white Score no score
Shape ROUND Size 6mm
Flavor Imprint Code K9
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:49884-310-02 60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077171 08/05/2005
Labeler — Par Pharmaceutical, Inc. (092733690)
Registrant — Par Pharmaceutical Inc. (092733690)

Revised: 01/2024 Par Pharmaceutical, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.